Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.03B |
| 2 |
Tesla
TSLA
|
+$1.19B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$840M |
| 4 |
State Street SPDR S&P Biotech ETF
XBI
|
+$589M |
| 5 |
Pinduoduo
PDD
|
+$576M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.43B |
| 2 |
Apple
AAPL
|
+$1.43B |
| 3 |
Amazon
AMZN
|
+$1.25B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.22B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$923M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.36% |
| 2 | Healthcare | 10.21% |
| 3 | Financials | 9.5% |
| 4 | Consumer Discretionary | 7.6% |
| 5 | Communication Services | 6.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
PUT
FedEx
FDX
$75.6B
| $11.1M | ﹤0.01% |
91,700
+23,000
| +33% | +$3.24M |
|
2002
First Trust Health Care AlphaDEX Fund
FXH
$1.07B
| $11.1M | ﹤0.01% |
150,001
+60,489
| +68% | +$4.91M |
|
2003
ICU Medical
ICUI
$4.54B
| $11.1M | ﹤0.01% |
54,986
+1,516
| +3% | +$292K |
|
2004
CALL
AB InBev
BUD
$166B
| $11.1M | ﹤0.01% |
251,200
+59,100
| +31% | +$3.86M |
|
2005
PUT
Teva Pharmaceuticals
TEVA
$40.9B
| $11.1M | ﹤0.01% |
1,233,800
-1,264,300
| -51% | -$13M |
|
2006
COPT Defense Properties
CDP
$4.23B
| $11.1M | ﹤0.01% |
500,188
+242,341
| +94% | +$6.58M |
|
2007
CVR Partners
UAN
$1.37B
| $11.1M | ﹤0.01% |
1,074,017
+5,000
| +0.5% | +$109K |
|
2008
CALL
eBay
EBAY
$50.2B
| $11.1M | ﹤0.01% |
367,600
+239,100
| +186% | +$8.33M |
|
2009
Rogers Corp
ROG
$2.4B
| $11M | ﹤0.01% |
116,806
-41,652
| -26% | -$4.74M |
|
2010
PUT
Expedia Group
EXPE
$36.9B
| $11M | ﹤0.01% |
195,700
-26,200
| -12% | -$2.52M |
|
|
BCPC
2011
Balchem Corp
BCPC
$5.73B
| $11M | ﹤0.01% |
111,008
+13,124
| +13% | +$1.34M |
|
|
ONC
2012
BeOne Medicines Ltd
ONC
$38.5B
| $10.9M | ﹤0.01% |
88,920
-181,866
| -67% | -$28.4M |
|
2013
iShares MSCI Philippines ETF
EPHE
$145M
| $10.9M | ﹤0.01% |
475,000
| – | – |
|
2014
Wabash National
WNC
$515M
| $10.9M | ﹤0.01% |
1,515,642
+137,435
| +10% | +$1.54M |
|
|
ILPT
2015
Industrial Logistics Properties Trust
ILPT
$581M
| $10.9M | ﹤0.01% |
622,639
+295,569
| +90% | +$6.21M |
|
2016
Natural Resource Partners
NRP
$1.42B
| $10.9M | ﹤0.01% |
894,123
+58,850
| +7% | +$985K |
|
|
RDS.A
2017
CALL
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $10.9M | ﹤0.01% |
312,600
+138,500
| +80% | +$6.47M |
|
2018
CALL
Intuitive Surgical
ISRG
$133B
| $10.9M | ﹤0.01% |
66,000
+43,800
| +197% | +$8.02M |
|
|
CMD
2019
DELISTED
Cantel Medical Corporation
CMD
| $10.9M | ﹤0.01% |
303,373
+102,557
| +51% | +$5.83M |
|
2020
Teck Resources
TECK
$32.7B
| $10.9M | ﹤0.01% |
1,440,343
-367,045
| -20% | -$4.4M |
|
2021
Webster Financial
WBS
$12.8B
| $10.9M | ﹤0.01% |
474,437
+154,984
| +49% | +$6.3M |
|
|
EQC
2022
DELISTED
Equity Commonwealth
EQC
| $10.8M | ﹤0.01% |
341,638
+142,109
| +71% | +$4.55M |
|
2023
Rocket Pharmaceuticals
RCKT
$379M
| $10.8M | ﹤0.01% |
776,517
+87,271
| +13% | +$1.73M |
|
2024
CNX Resources
CNX
$5.21B
| $10.8M | ﹤0.01% |
2,035,155
-958,678
| -32% | -$6.37M |
|
|
RVNC
2025
DELISTED
Revance Therapeutics, Inc.
RVNC
| $10.8M | ﹤0.01% |
731,534
+623,626
| +578% | +$12.9M |
|
Similar funds
Goldman Sachs's Q1 2020 Portfolio in Review
As of Q1 2020, Goldman Sachs held 5,784 positions worth $284B, down 28% from $393B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Goldman Sachs withdrew a net $27.9B in Q1 2020, closing 606 positions and reducing 2,198 holdings. Its most notable exit was Wellcare Health Plans, Inc., an estimated $731M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Goldman Sachs opened a new position in Vertiv worth $138M.
- Goldman Sachs's largest Q1 2020 buy was Vertiv: 15,967,049 shares worth $138M.
- Goldman Sachs added most to State Street SPDR S&P 500 ETF Trust in Q1 2020, an estimated $4.03B increase.
- Goldman Sachs's biggest Q1 2020 reduction was Microsoft, cutting an estimated $2.43B.
- Goldman Sachs fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $731M.
- Goldman Sachs's ten largest holdings make up 18% of its $284B portfolio in Q1 2020.
- Goldman Sachs opened 600 new positions and closed 606 in Q1 2020.
- Goldman Sachs's portfolio value fell 28% quarter-over-quarter to $284B.
Based on Goldman Sachs's 13F filing for Q1 2020, filed 15 May 2020.